Veículo
Brazil Posts English
Em 2024: 8 notícias
Desde 1995: 74 notícias
5G has barely arrived and Brazil already has a laboratory to develop 6G
Publicado em 11 dezembro 2022
5G, the fifth generation of mobile telephony that provides faster and more stable internet, began to be implemented in Brasilia in July and, little by little, has reached the capitals. While the technology isn’t everywhere, researchers are already eyeing 6G, the next technological evolution.
This week, the Center for Research in Engineering in Networks and Intelligent Services for 2030 (Smartness) was inaugurated – made up of FAPESP (Foundation for Research Support of the State [...]
-
Covid-19: Model vaccination in Serrana (SP) reduced deaths and serious cases; understand the study
Publicado em 09 dezembro 2022AGÊNCIA FAPESP – Research carried out in Serrana (SP), a model city for immunization against Covid-19 in Brazil, proved that the mass vaccination it reduced death rates and severe cases of the disease even during the circulation of the gamma and delta variants, considered worrying due to their faster dissemination than previous strains. Based on the evolutionary analysis of SARS-CoV-2 (phylogenetics), the scientists showed that the virus replacement dynamics in the city was [...]ver notícia -
Covid-19: loss of muscle mass in infection indicates higher risk of long covid
Publicado em 07 dezembro 2022Patients who lose muscle mass in the acute phase of covid-19, when they are hospitalized, are at high risk of developing long-term covid. According to Brazilian researchers, the more “muscles” a person loses, the greater the chance of facing sequelae from the infection. Published in scientific journal Journal of the American Medical Directors Association (Jamda) the study that associates long-term covid with muscle loss in the acute phase of the disease was led by researchers [...]ver notícia -
Old studies with little impact gained visibility in the pandemic and helped in the fight against the new coronavirus : Pesquisa Fapesp Magazine
Publicado em 01 dezembro 2022A curious phenomenon in scientometrics, an area that studies scientific production based on indicators, has reappeared during the pandemic: the “sleeping beauties”, articles that start to receive citations years or decades after they were published. More than a dozen works released between 2003 and 2015 – and which, until then, had had little or no repercussion – “wake up” in the midst of the health crisis, gaining importance in the fight against the new [...]ver notícia -
National vaccine against Covid-19 starts clinical trials
Publicado em 27 novembro 2022The Faculty of Medicine of the Federal University of Medicine of Minas Gerais (UFMG) started this Friday (25) the clinical studies of the first national vaccine against covid-19. The SpiN-Tec MCTI UFMG immunization is the first developed with national technology and inputs, in addition to being financed with resources from Brazilian institutions. According to Agência Brasil, during an event held in Belo Horizonte, the Secretary of Research and Scientific Training of the Ministry of [...]ver notícia -
Brazilian vaccine for Covid-19 begins to be evaluated in humans; understand how the tests will be
Publicado em 27 novembro 2022Last Friday, the first three volunteers received a dose of the vaccine against Covid-19 SpiN-TEC, created by the Vaccines Center of the Federal University of Minas Gerais (CTVacinas / UFMG), in partnership with Fiocruz Minas and the Ministry of Science, Technology and Innovation (MCTI). The event marked the beginning of phase 1 of clinical trials of the immunizer, the first developed entirely with national technology and inputs. Resistant microbes: Crisis in antibiotic research may [...]ver notícia -
Vaccine against covid-19 developed in Brazil begins to be tested in humans
Publicado em 26 novembro 2022With over a thousand enrolled to participate in clinical trials, the Faculdade de Medicina da Federal University of Minas Gerais (UFMG) in Belo Horizonte, started applying this Friday, 25th, the first vaccine against Covid-19 developed with totally Brazilian technologies and inputs and financed by national institutions. The immunizer is still in the testing phase. Named SpiN-Tec MCTI UFMG, the vaccine was produced at the Vaccine Technology Center (CTVacinas) at UFMG in partnership with [...]ver notícia -
Brazilian vaccine against Covid-19 begins to be applied to humans today at UFMG
Publicado em 25 novembro 2022The Federal University of Minas Gerais (UFMG) begins to apply today (25) the first vaccine against Covid-19 entirely produced in Brazil. This will be the first phase of clinical studies in humans from SpiN-Tec MCTI UFMG. The dose will be applied at the Faculty of Medicine of UFMG and will be transmitted via Federal channel on Youtube. SpiN-Tec was developed with totally national technology and inputs, in a partnership between UFMG and Fundação Oswaldo Cruz. The vaccine was [...]ver notícia -
Tec | National covid-19 vaccine begins to be tested in Minas Gerais
Publicado em 25 novembro 2022On Friday (25), the first doses of a potential vaccine against covid-19 will begin to be applied in Belo Horizonte, capital of Minas Gerais. Officially known as SpiN-Tec MCTI UFMG, the immunizer that uses 100% national technology should be applied to approximately 70 people in the first phase of the clinical study. The national vaccine against covid-19 is developed by researchers at the Federal University of Minas Gerais (UFMG) and has the support of the Ministry of Science, Technology and [...]ver notícia -
UFMG immunizes first volunteer with national vaccine against Covid-19 – News
Publicado em 25 novembro 2022The first application of the SpiN-Tec clinical test in humans was carried out on the morning of this Friday (25), at the Faculty of Medicine of the UFMG (Federal University of Minas Gerais), in the Santa Efigênia neighborhood, in the south-central region of Belo Horizonte. Horizon. The immunizer is the first developed with national technologies and products. The vaccine was created at CTVacinas (Vaccine Technology Center), in partnership with Fiocruz Minas (Oswaldo Cruz Foundation in [...]ver notícia